PATENT CLAIM ANALYSIS

Application Number: 15883218
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "145100"]

Abstract:
The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.

Claim (Index 17):
The method of  claim 1 , wherein the antibody and the additional agent are administered simultaneously.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 86.0
- Lexical Diversity: 1.24444
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15588432', '15588461', '14719015', '13179846', '15044552']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8558305511447124
- 35 USC 102 Novelty (BERT): 0.6202534472659761
- Combined Prediction Score: 0.8322728407568388
- Mean Citation Score: 697.1334599999999
- Max Citation Score: 710.2112
- Similarity Product: 466.9679481803894

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test